Molecular pathogenesis of bone marrow disorders in dogs

113

Arber, D. A., Orazi, A., Hasserjian, R., Borowitz, M. J., Beau, M. M. Le, Bloomfield,

C. D., Cazzola, M., & Vardiman, J. W. (2016). The 2016 revision to the World

Health Organization classi fi cation of myeloid neoplasms and acute leukemia.

Blood, 127, 2391–2405.

Asada, S., Fujino, T., Goyama, S., & Kitamura, T. (2019). The role of ASXL1 in

hematopoiesis and myeloid malignancies. Cellular and Molecular Life Sciences,

76, 2511–2523.

Baek, S. H., Kioussi, C., Briata, P., Wang, D., Nguyen, H. D., Ohgi, K. A., Glass, C. K.,

Wynshaw-Boris, A., Rose, D. W., & Rosenfeld, M. G. (2003). Regulated subset of

G1 growth-control genes in response to derepression by the Wnt pathway.

Proceedings of the National Academy of Sciences of the United States of America,

100, 3245–3250.

Barqué, A., Jan, K., De La Fuente, E., Nicholas, C. L., Hynes, R. O., & Naba, A.

(2020). Knockout of the gene encoding the extracellular matrix protein SNED1

results in early neonatal lethality and craniofacial malformations. Developmental

Dynamics, in press.

Bennett, J. M., Catovsky, D., Daniel, M. T., Flandrin, G., Galton, D. A. G., Gralnick, H.

R., & Sultan, C. (1982). Proposals for the classification of the myelodysplastic

syndromes. British Journal of Haematology, 51, 189–199.

Bernstein, B. E., Meissner, A., & Lander, E. S. (2007). The Mammalian Epigenome.

Cell, 128, 669–681.

Bird, A. (2002). DNA methylation patterns and epigenetic memory. Genes and

Development, 16, 6–21.

Blue, J. T. (2003). Myelodysplasia: Differentiating Neoplastic from Nonneoplastic

Syndromes of Ineffective Hematopoiesis in Dogs. Toxicologic Pathology, 31, 44–

48.

Bovolenta, P., Esteve, P., Ruiz, J. M., Cisneros, E., & Lopez-Rios, J. (2008). Beyond

Wnt inhibition: New functions of secreted Frizzled-related proteins in development

and disease. Journal of Cell Science, 121, 737–746.

Bowen, D., Culligan, D., Jowitt, S., Kelsey, S., Mufti, G., Oscier, D. G., & Parker, J.

(2003). Guidelines for the diagnosis and therapy of adult myelodysplastic

syndromes. British Journal of Haematology, 120, 187–200.

114

Brazzell, J. L., & Weiss, D. J. (2006). A retrospective study of aplastic pancytopenia in

the dog: 9 Cases (1996-2003). Veterinary Clinical Pathology, 35, 413–417.

Cheson, B. D., Greenberg, P. L., Bennett, J. M., Lowenberg, B., Wijermans, P. W.,

Nimer, S. D., Pinto, A., Beran, M., Witte, T. M., Stone, R. M., Mittelman, M.,

Sanz, G. F., Gore, S. D., Schiffer, C. A., & Kantarjian, H. (2006). Clinical

application and proposal for modification of the InternationalWorking Group

(IWG) response criteria in myelodysplasia. Blood, 108, 419–425.

Clevers, H. (2006). Wnt/β-Catenin Signaling in Development and Disease. Cell, 127,

469–480.

Colella, S., Shen, L., Baggerly, K. A., Issa, J. P. J., & Krahe, R. (2003). Sensitive and

quantitative universal PyrosequencingTM methylation analysis of CpG sites.

BioTechniques, 35, 146–150.

Duan, W. R., Gamer, D. S., Williams, S. D., Funckes-Shippy, C. L., Spath, I. S., &

Blomme, E. A. G. (2003). Comparison of immunohistochemistry for activated

caspase-3 and cleaved cytokeratin 18 with the TUNEL method for quantification

of apoptosis in histological sections of PC-3 subcutaneous xenografts. Journal of

Pathology, 199, 221–228.

Figueroa, M. E., Skrabanek, L., Li, Y., Jiemjit, A., Fandy, T. E., Paietta, E., Fernandez,

H., Tallman, M. S., Greally, J. M., Carraway, H., Licht, J. D., Gore, S. D., &

Melnick, A. (2009). MDS and secondary AML display unique patterns and

abundance of aberrant DNA methylation. Blood, 114, 3448–3458.

Font, P., Loscertales, J., Benavente, C., Bermejo, A., Callejas, M., Garcia-Alonso, L.,

Garcia-Marcilla, A., Gil, S., Lopez-Rubio, M., Martin, E., Muñoz, C., Ricard, P.,

Soto, C., Balsalobre, P., & Villegas, A. (2013). Inter-observer variance with the

diagnosis of myelodysplastic syndromes (MDS) following the 2008 WHO

classification. Annals of Hematology, 92, 19–24.

Gardiner-Garden, M., & Frommer, M. (1987). CpG Islands in Vertebrate Genomes.

Journal of Molecular Biology, 196, 261–282.

Hattori, A., Sanada, M., Kojima, T., Ihzumi, T., Koike, T., Nagayama, R., & Shibata, A.

(1981). Studies on platelet shape and function 9th report bipolar platelets. Blood &

Vessel, 12, 182–187.

Herman, J. G., & Baylin, S. B. (2003). Gene Silencing in Cancer in Association with

115

Promoter Hypermethylation. New England Journal of Medicine, 349, 2042–2054.

Honda, T., Uehara, T., Matsumoto, G., Arai, S., & Sugano, M. (2016). Neutrophil left

shift and white blood cell count as markers of bacterial infection. Clinica Chimica

Acta, 457, 46–53.

Hynes, R. O. (2009). The extracellular matrix: Not just pretty fibrils. Science, 326,

1216–1219.

Imielinski, M., Berger, A. H., Hammerman, P. S., Hernandez, B., Pugh, T. J., Hodis, E.,

Cho, J., Suh, J., Capelletti, M., Sivachenko, A., Sougnez, C., Auclair, D.,

Lawrence, M. S., Stojanov, P., Cibulskis, K., Choi, K., De Waal, L., Sharifnia, T.,

Brooks, A., … Meyerson, M. (2012). Mapping the hallmarks of lung

adenocarcinoma with massively parallel sequencing. Cell, 150, 1107–1120.

Inoue, M., Hasegawa, A., Hosoi, Y., & Sugiura, K. (2015). Breed, gender and age

pattern of diagnosis for veterinary care in insured dogs in Japan during fiscal year

2010. Preventive Veterinary Medicine, 119, 54–60.

Jain, N. C., Blue, J. T., Grindem, C. B., Harvey, J. W., Koclba, G. J., Krehbiel, J. D.,

Latimer, K. S., Raskin, R. E., Thrall, M. A., & Zinkl, J. G. (1991). Proposed

Criteria for Classification of Acute Myeloid Leukemia in Dogs and Cats.

Veterinary Clinical Pathology, 20, 63–82.

Jelinek, J., Liang, S., Lu, Y., He, R., Ramagli, L. S., Shpall, E. J., Estecio, M. R. H., &

Issa, J. P. J. (2012). Conserved DNA methylation patterns in healthy blood cells

and extensive changes in leukemia measured by a new quantitative technique.

Epigenetics, 7, 1368–1378.

Larrivée, B., Pollet, I., & Karsan, A. (2005). Activation of Vascular Endothelial Growth

Factor Receptor-2 in Bone Marrow Leads to Accumulation of Myeloid Cells: Role

of Granulocyte-Macrophage Colony-Stimulating Factor. The Journal of

Immunology, 175, 3015–3024.

Leiva, O., Leon, C., Kah Ng, S., Mangin, P., Gachet, C., & Ravid, K. (2018). The role

of extracellular matrix stiffness in megakaryocyte and platelet development and

function. American Journal of Hematology, 93, 430–441.

Liles, W. C., Dale, D. C., & Klebanoff, S. J. (1995). Glucocorticoids inhibit apoptosis

of human neutrophils. Blood, 86, 3181–3188.

Lucidi, C. de A., de Rezende, C. L. E., Jutkowitz, L. A., & Scott, M. A. (2017).

116

Histologic and cytologic bone marrow findings in dogs with suspected precursortargeted immune-mediated anemia and associated phagocytosis of erythroid

precursors. Veterinary Clinical Pathology, 46, 401–415.

MacDonald, B. T., Tamai, K., & He, X. (2009). Wnt/β-Catenin Signaling: Components,

Mechanisms, and Diseases. Developmental Cell, 17, 9–26.

Margolskee, E., Hasserjian, R. P., Hassane, D., Tam, W., Mathew, S., Ok, C. Y., Wang,

S. A., Oak, J., Arber, D. A., & Orazi, A. (2017). Myelodysplastic Syndrome,

Unclassifiable (MDS-U) with 1% blasts is a distinct subgroup of MDS-U with a

poor prognosis. American Journal of Clinical Pathology, 148, 49–57.

Mochizuki, H., Goto-Koshino, Y., Takahashi, M., Fujino, Y., Ohno, K., & Tsujimoto,

H. (2015). Demonstration of the Cell Clonality in Canine Hematopoietic Tumors

by X-chromosome Inactivation Pattern Analysis. Veterinary Pathology, 52, 61–69.

Mohamedali, A. M., Alkhatabi, H., Kulasekararaj, A., Shinde, S., Mian, S., Malik, F.,

Smith, A. E., Gäken, J., & Mufti, G. J. (2013). Utility of peripheral blood for

cytogenetic and mutation analysis in myelodysplastic syndrome. Blood, 122, 567–

570.

Mossner, M., Nolte, F., Hütter, G., Reins, J., Klaumünzer, M., Nowak, V., Obländer, J.,

Ackermann, K., Will, S., Röhl, H., Neumann, U., Neumann, M., Hopfer, O.,

Baldus, C. D., Hofmann, W. K., & Nowak, D. (2013). Skewed X-inactivation

patterns in ageing healthy and myelodysplastic haematopoiesis determined by a

pyrosequencing based transcriptional clonalityll assay. Journal of Medical

Genetics, 50, 108–117.

Nagase, R., Inoue, D., Pastore, A., Fujino, T., Hou, H.-A., Yamasaki, N., Goyama, S.,

Saika, M., Kanai, A., Sera, Y., Horikawa, S., Ota, Y., Asada, S., Hayashi, Y.,

Kawabata, K. C., Takeda, R., Tien, H.-F., Honda, H., Abdel-Wahab, O., &

Kitamura, T. (2018). Expression of mutant Asxl1 perturbs hematopoiesis and

promotes susceptibility to leukemic transformation. The Journal of Experimental

Medicine, 215, 1729–1747.

Ogawa, S. (2019). Genetics of MDS. Blood, 133, 1049–1059.

Ohmi, A., Tsukamoto, A., Ohno, K., Uchida, K., Nishimura, R., Fukushima, K.,

Takahashi, M., Nakashima, K., Fujino, Y., & Tsujimoto, H. (2012). A

Retrospective Study of Inflammatory Colorectal Polyps in Miniature Dachshunds.

117

Journal of Veterinary Medical Science, 74, 59–64.

Ohta, H., Yamazaki, J., Jelinek, J., Ishizaki, T., Kagawa, Y., Yokohama, N., Nagata, N.,

Sasaki, N., & Takiguchi, M. (2020). Genome-wide DNA methylation analysis in

canine gastrointestinal lymphoma. Journal of Veterinary Medical Science, 82,

632–638.

Peters, I. R., Peeters, D., Helps, C. R., & Day, M. J. (2015). Development and

application of multiple internal reference (housekeeper) gene assays for accurate

normalisation of canine gene expression studies. Veterinary Immunology and

Immunopathology, 117, 55–66.

Qiao, J., Rellinger, E. J., Kim, K. W., Powers, C. M., Lee, S., Correa, H., & Chung, D.

H. (2019). Identification of α-N-catenin as a novel tumor suppressor in

neuroblastoma. Oncotarget, 10, 5028–5040.

Reya, T., Duncan, A. W., Ailles, L., Domen, J., Scherer, D. C., Willert, K., Hintz, L.,

Nusse, R., & Weissman, I. L. (2003). A role for Wnt signalling in self-renewal of

haematopoietic stem cells. Nature, 423, 409–414.

Senent, L., Arenillas, L., Luño, E., Ruiz, J. C., Sanz, G., & Florensa, L. (2013).

Reproducibility of the World Health Organization 2008 criteria for

myelodysplastic syndromes. Haematologica, 98, 568–575.

Shetty, V., Hussaini, S., Alvi, S., Joshi, L., Shaher, A., Dangerfield, B., Nascimben, F.,

Mundle, S., Allampallam, K., Reddy, P., Galili, N., & Raza, A. (2002). Excessive

apoptosis, increased phagocytosis, nuclear inclusion bodies and cylindrical

confronting cisternae in bone marrow biopsies of myelodysplastic syndrome

patients. British Journal of Haematology, 116, 817–825.

Stoddart, A., Wang, J., Hu, C., Fernald, A. A., Davis, E. M., Cheng, J. X., & Le Beau,

M. M. (2017). Inhibition of WNT signaling in the bone marrow niche prevents the

development of MDS in the Apcdel/+ MDS mouse model. Blood, 129, 2959–2970.

Stokol, T., Blue, J. T., & French, T. W. (2000). Idiopathic pure red cell aplasia and

Nonregenerative Immune-Mediated Anemia in Dogs : 43 Cases ( 1988 – 1999 ).

Journal of the American Veterinary Medical Association, 216, 1429–1436.

Tomita, A., Mochizuki, H., Tsuboi, M., Ogura, I., Igarashi, H., Goto-Koshino, Y.,

Takahashi, M., Ohmi, A., Tomiyasu, H., Ohno, K., Nakagawa, T., Uchida, K.,

Nishimura, R., & Tsujimoto, H. (2019). Development of canine X-chromosome

118

inactivation pattern analysis for the detection of cell clonality by incorporating the

examination of the SLIT and NTRK-like family member 4 (SLITRK4) gene.

Research in Veterinary Science, 125, 170–175.

Turinelli, V., Gavazza, A., Stock, G., & Fournel-Fleury, C. (2015). Canine bone

marrow cytological examination, classification and reference values: A

retrospective study of 295 cases. Research in Veterinary Science, 103, 224–230.

Valencia, A., Román-Gómez, J., Cervera, J., Such, E., Barragán, E., Bolufer, P.,

Moscardó, F., Sanz, G. F., & Sanz, M. A. (2009). Wnt signaling pathway is

epigenetically regulated by methylation of Wnt antagonists in acute myeloid

leukemia. Leukemia, 23, 1658–1666.

Valent, P., Horny, H. P., Bennett, J. M., Fonatsch, C., Germing, U., Greenberg, P.,

Haferlach, T., Haase, D., Kolb, H. J., Krieger, O., Loken, M., van de Loosdrecht,

A., Ogata, K., Orfao, A., Pfeilstöcker, M., Rüter, B., Sperr, W. R., Stauder, R., &

Wells, D. A. (2007). Definitions and standards in the diagnosis and treatment of

the myelodysplastic syndromes: Consensus statements and report from a working

conference. Leukemia Research, 31, 727–736.

Walter, M. J., Shen, D., Ding, L., Shao, J., Koboldt, D. C., Chen, K., Larson, D. E.,

McLellan, M. D., Dooling, D., Abbott, R., Fulton, R., Magrini, V., Schmidt, H.,

Kalicki-Veizer, J., O’Laughlin, M., Fan, X., Grillot, M., Witowski, S., Heath, S.,

… Graubert, T. A. (2012). Clonal Architecture of Secondary Acute Myeloid

Leukemia. New England Journal of Medicine, 366, 1090–1098.

Wang, H., Fan, R., Wang, X. Q., Wu, D. P., Lin, G. W., Xu, Y., & Li, W. Y. (2013).

Methylation of Wnt antagonist genes: A useful prognostic marker for

myelodysplastic syndrome. Annals of Hematology, 92, 199–209.

Wang, W., Tang, Y., Ni, L., Kim, E., Jongwutiwes, T., Hourvitz, A., Zhang, R., Xiong,

H., Liu, H. C., & Rosenwaks, Z. (2012). Overexpression of Uromodulin-like1

accelerates follicle depletion and subsequent ovarian degeneration. Cell Death and

Disease, 3, 1–14.

Watson, A. D. J., Duff, B. C., & Allan, G. S. (1975). Erythrocyte Aplasia in a Dog.

Australian Veterinary Journal, 51, 94–96.

Wawrzak, D., Métioui, M., Willems, E., Hendrickx, M., Genst, E. de, & Leyns, L.

(2007). Wnt3a binds to several sFRPs in the nanomolar range. Biochemical and

119

Biophysical Research Communications, 357, 1119–1123.

Weiss, D. J. (2002). Primary pure red cell aplasia in dogs: 13 cases (1996-2000).

Journal of the American Veterinary Medical Association, 221, 93–95.

Weiss, D. J. (2005). Bone marrow necrosis in dogs: 34 cases (1996-2004). Journal of

the American Veterinary Medical Association, 227, 263–267.

Weiss, D. J. (2006). A retrospective study of the incidence and the classification of bone

marrow disorders in the dog at a veterinary teaching hospital (1996-2004). Journal

of Veterinary Internal Medicine, 20, 955–961.

Weiss, D. J., & Aird, B. (2001). Cytologic Evaluation of Primary and Secondary

Myelodysplastic Syndromes in the Dog. Veterinary Clinical Pathology, 30, 67–75.

Weiss, D. J., Evanson, O. A., & Sykes, J. (1999). A retrospective study of canine

pancytopenia. Veterinary Clinical Pathology, 28, 83–88.

Weiss, D. J., & Klausner, J. S. (1990). Drug-associated aplastic anemia in dogs: eight

cases (1984-1988). Journal of the American Veterinary Medical Association, 196,

472–475.

Weiss, D. J., & Smith, S. A. (2000). Primary myelodysplastic syndromes of dogs: A

report of 12 cases. Journal of Veterinary Internal Medicine / American College of

Veterinary Internal Medicine, 14, 491–494.

Weiss, D. J., & Smith, S. A. (2002). A retrospective study of 19 cases of canine

myelofibrosis. J Vet Intern Med, 16, 174–178.

Xu, J., Suzuki, M., Niwa, Y., Hiraga, J., Nagasaka, T., Ito, M., Nakamura, S., Tomita,

A., Abe, A., Kiyoi, H., Kinoshita, T., & Naoe, T. (2008). Clinical significance of

nuclear non-phosphorylated beta-catenin in acute myeloid leukaemia and

myelodysplastic syndrome. British Journal of Haematology, 140, 394–401.

Yamagishi, C., Momoi, Y., Kobayashi, T., Ide, K., Ohno, K., Tsujimoto, H., & Iwasaki,

T. (2007). A retrospective study and gene analysis of canine sterile panniculitis.

Journal of Veterinary Medical Science, 69, 915–924.

Yamazaki, J., Jelinek, J., Hisamoto, S., Tsukamoto, A., & Inaba, M. (2018). Dynamic

changes in DNA methylation patterns in canine lymphoma cell lines demonstrated

by genome-wide quantitative DNA methylation analysis. The Veterinary Journal,

231, 48–54.

Yoshida, Y. (1996). Characteristics and pathology of myelodysplastic syndrome. The

120

Oncologist, 1, 284–287.

121

...